Maravai LifeSciences

Maravai LifeSciences

Biotechnology Research

San Diego, California 8,359 followers

Extraordinary science. Everyday miracles.

About us

Maravai brands set the standard in nucleic acid products and services, enzyme development, and biologics safety testing. From producing revolutionary mRNA technologies that drive infectious disease vaccines, cancer vaccines, and other cell and gene therapies to delivering gold-standard bioprocess impurity detection solutions, Maravai is helping life sciences companies overcome their biggest development and manufacturing challenges to streamline and scale from research through clinical trials to commercialization. For over 35 years, Maravai’s brands have served as proven catalysts for innovative, lifesaving technology for humanity. Across our portfolio of brands, we hold numerous patents and offer more than 1,500 innovative products and services, including CleanCap® technology, CleanAmp® hot start PCR, Antibody Affinity Extraction™, EndonucleaseGTP®, PROTEIN A MIX-N-GO™, MockV®, Sterling™, Glen Pak™, Glen Gel-Pak™. Each of our brands are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications.

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
San Diego, California
Type
Public Company
Founded
2014
Specialties
mRNA, CDMO Services, Impurity Detection Assays, Molecular Diagnostic Tools, Nucleic Acid Production, Life Sciences, Biotechnology, Nucleotide Synthesis, Oligonucleotides, DNA, RNA, Genomics, Gene Therapy, Bioprocess Impurity Detection, Host Cell Protein Experts, mRNA Experts, Molecular Biology, Enzymes, Custom Chemistry, and Nucleic Acid Therapies

Locations

Employees at Maravai LifeSciences

Updates

Similar pages

Browse jobs

Funding

Maravai LifeSciences 2 total rounds

Last Round

Post IPO equity

US$ 1.0B

See more info on crunchbase